MedPath

Evaluation of PET Scan Timing Relative to AV-45 Injection Time

Not Applicable
Completed
Conditions
Alzheimer's Disease
Registration Number
NCT01565356
Lead Sponsor
Avid Radiopharmaceuticals
Brief Summary

This study will re-read 10-minute positron emission tomography (PET) scans acquired in previous clinical studies of AV-45 at 30 and 50 minutes after injection and compare the results.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
41
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Percent Agreement of Interpretation Between 30-40 and 50-60 Min Reads - Qualitative EvaluationScans acquired 30-40 min and 50-60 min after injection

Three independent readers blinded to subject identification, subject diagnosis, subject demographics and PET scan time points post-injection read each scan and reported as amyloid positive or amyloid negative. Results show the percentage of agreement between the majority read of 30-40 min scan and the majority read of the 50-60 min scan.

Secondary Outcome Measures
NameTimeMethod
Agreement of Interpretation Between 30-40 and 50-60 Min Reads - Semi-quantitative EvaluationScans acquired 30-40 min and 50-60 min post-injection

Three independent readers blinded to subject identification, subject diagnosis, subject demographics and PET scan time points post-injection read each scan and reported the results using a 5-point scale (0=no amyloid; 4=high levels of amyloid deposition). Results are reported as a weighted kappa statistic.

© Copyright 2025. All Rights Reserved by MedPath